U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07165197) titled 'Visual Performance of Clareon Vivity and PureSee IOL' on Aug. 25.
Brief Summary: This is study to determine the visual performance of patients with age-related cataracts implanted in both eyes with either of two extended depth of focus intraocular lenses, the Clareon Vivity (Alcon Healthcare) or the PureSee (Johnson & Johnson)
Study Start Date: June 27
Study Type: INTERVENTIONAL
Condition:
Cataract
Intervention:
DEVICE: Phacoemulsification with implantation of an extended depth of focus intraocular lens
Comparison of two different Extended depth of focus intraocular lenses
Recruitment Status: RECRUITING
Sponsor: OMIQ Resea...